Oral PCSK9 inhibitor is effective and safe
- PMID: 36944789
- DOI: 10.1038/s41569-023-00864-4
Oral PCSK9 inhibitor is effective and safe
Comment on
-
Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616.J Am Coll Cardiol. 2023 Apr 25;81(16):1553-1564. doi: 10.1016/j.jacc.2023.02.018. Epub 2023 Mar 6. J Am Coll Cardiol. 2023. PMID: 36889610 Clinical Trial.
References
Original article
-
- Ballantyne, C. M. et al. Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial. J. Am. Coll. Cardiol. https://doi.org/10.1016/j.jacc.2023.02.018 (2023) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
